idecabtagene vicleucel,lenalidomide
bms,2seventy bio
['karmma', 'karmma-2', 'mmsm']
#ash22 #mmsm in karmma-2a, mpfs of less than 1 year is not what we like to see- more work to be done for this subset of patients 
Assistant professor @UAMSMyeloma. Alumni heme/onc @bcmhouston, clinical research/biostat @UMich.Focus on plasma cell disorders & health disparities